GPR119 receptor

Last updated on: 16.05.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The GPR119 receptor protein is a G protein-coupled receptor that is expressed in the pancreas, gastrointestinal tract and sebaceous glands, among others. Ligands of this receptor protein are the endogenous fatty acid ethanolamides oleoylethanolamide (OEA) and lysophosphatidylcholine (LPC). The recptor functions as a glucose-dependent insulinotropic receptor . Its activity is mediated by G proteins that activate adenylate cyclase.

GPR119 has also been shown to regulate the secretion of the hormones incretin and insulin (Ning Y et al. 2008). Furthermore, GPR119 was shown to be downregulated in the sebaceous glands of patients with acne. This may indicate that GPR119 signaling is impaired in acne. Apparently, the OEA/GPR119 signaling pathway is considered a positive regulator of sebocyte differentiation. Dysregulation of this pathway could contribute to the development of seborrhea and acne (Markovics A et al. 2020).

Note(s)This section has been translated automatically.

The GPR119 protein is a potential drug target for the treatment of type 2 diabetes.

Associated diseases associated with mutations in the GPR119 gene include type 2 diabetes mellitus.

LiteratureThis section has been translated automatically.

  1. Markovics A et al (2020) GPR119 Is a Potent Regulator of Human Sebocyte Biology. J Invest Dermatol 140:1909-1918.e8.
  2. Ning Y et al. (2008) Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. British Journal of Pharmacology 155: 1056-1065.
  3. Swaminath G (2008). Fatty acid binding receptors and their physiological role in type 2 diabetes. Archives of Pharmacy 341: 753-761.
  4. Lan H et al. (2009) GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. The Journal of Endocrinology 201: 219-230.

Last updated on: 16.05.2021